tiprankstipranks
Luye Pharma Group Ltd. (LYPHF)
OTHER OTC:LYPHF
US Market
LYPHF
Luye Pharma Group
RESEARCH TOOLSreports
Want to see LYPHF full AI Analyst Report?

Luye Pharma Group (LYPHF) Income Statement

3 Followers

Luye Pharma Group Income Statement

Last quarter (Q4 2025), Luye Pharma Group's total revenue was ¥3.08B, a decrease of -5.06% from the same quarter last year. In Q4, Luye Pharma Group's net income was ¥300.76M. See Luye Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 6.15B¥ 6.06B¥ 6.14B¥ 5.98B¥ 5.20B
Gross Profit
¥ 4.05B¥ 4.04B¥ 4.20B¥ 4.14B¥ 3.40B
Operating Expenses
¥ 2.84B¥ 2.90B¥ 3.29B¥ 3.26B¥ 2.96B
Depreciation and Amortization
¥ 817.77M¥ 665.47M¥ 701.85M¥ 671.31M¥ 581.98M
EBITDA
¥ 2.03B¥ 1.79B¥ 2.08B¥ 1.81B¥ 906.88M
Operating Income
¥ 1.21B¥ 1.15B¥ 917.88M¥ 880.62M¥ 437.96M
Other Income/Expenses
¥ -290.52M¥ -308.03M¥ -217.78M¥ -210.86M¥ 0.00
Pretax Income
¥ 920.19M¥ 839.22M¥ 700.10M¥ 669.76M¥ -74.56M
Net Income
¥ 602.73M¥ 471.89M¥ 532.61M¥ 604.81M¥ -134.39M
Per Share Metrics
Basic EPS
¥ 0.15¥ 0.13¥ 0.14¥ 0.17¥ -0.04
Diluted EPS
¥ 0.15¥ 0.13¥ 0.14¥ 0.17¥ -0.04
Weighted Average Shares Outstanding
 3.90B 3.76B 3.73B 3.48B 3.45B
Weighted Average Shares Outstanding (Diluted)
 3.90B 3.76B 3.73B 3.48B 3.45B
Currency in CNY

Luye Pharma Group Earnings and Revenue History